ArticleBMC cancer2024

Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD).

Ao Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.